SCHEMBL26745334

SCHEMBL26745334

c1ccc(-c2ncc(-c3nc4cc5cc6sc(-c7cnc(-c8ccccc8)s7)nc6cc5cc4s3)s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.48
▸ SMN1; SMN2 Q16637 6/20 0.48
▸ ALDH1A1 P00352 6/20 0.48
▸ HPGD P15428 6/20 0.48
▸ MAPT P10636 4/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ PKM P14618 2/20 0.48
▸ GLA P06280 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ NPC1 O15118 11/20 0.46
▸ RAB9A P51151 11/20 0.46
▸ NFKB1 P19838 6/20 0.46
▸ NFKB2 Q00653 6/20 0.46
▸ RELA Q04206 6/20 0.46
▸ LMNA P02545 4/20 0.46
▸ HPGDS O60760 2/20 0.46
▸ HSD17B1 P14061 2/20 0.42
▸ HSD17B2 P37059 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26745138 0.92 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745131 0.89 HDAC4 (0.42) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745348 0.88 HSD17B1 (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745566 0.87 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745337 0.86 HSD17B1 (0.40) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745352 0.85 PDGFRB (0.43) KDM4EKMT2AMEN1NPC1RAB9A
SCHEMBL26745356 0.84 RAB9A (0.49) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26746755 0.84 KDM4E (0.64) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26745122 0.82 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26744930 0.80 KDM4E (0.60) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND TEAD1, CRY1, CPNE4 KDM4E 1242/4885SMN1; SMN2 3799/4885ALDH1A1 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback